Clinical Trial Update: Montelukast and Nasal Epithelial Cell Inflammatory Responses in Asthma and Rhinitis

View source ↗

Summary

The update covers a study evaluating montelukast's impact on nasal epithelial cell inflammatory responses in individuals with asthma and allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: University of Aberdeen | Conditions: Asthma, Allergic Rhinitis | Status: UNKNOWN